4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-086385
Chief Executive Officer sold 2,794 shares at $4.37 ($12,210)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2021-06-28 | Sale | −2,794 | $4.37 | $12,210 | 3,058 | D |
| Open-market sales · 2,794 sh · avg $4.37 · $12,210 | |||||||
Loading xslF345X03/tm2118429-2_4seq1.xml…